X. Song, “Targeting of both PI3K/Akt/mTOR pathway and mutant EGFR to overcome resistance to tyrosine kinase inhibitors in mutant EGFR-mediated lung cancer”, OR, vol. 1, no. 1, pp. pp.13–19, Nov. 2013, doi: 10.14259/or.v1i1.81.